CANCER OF ENDOMETRIUM
Clinical trials for CANCER OF ENDOMETRIUM explained in plain language.
Never miss a new study
Get alerted when new CANCER OF ENDOMETRIUM trials appear
Sign up with your email to follow new studies for CANCER OF ENDOMETRIUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets aggressive uterine cancer
Disease control Recruiting nowThis study tests a mix of two approved drugs plus an experimental vaccine and an immune booster for people with advanced HER2-positive endometrial cancer that has returned or worsened. The vaccine is made from each participant's own blood cells and targets the HER2 protein. The g…
Matched conditions: CANCER OF ENDOMETRIUM
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 06:59 UTC
-
Magic mushroom therapy targets Cancer-Related anxiety in new trial
Symptom relief Recruiting nowThis study tests whether a drug called NPX-5 (psilocybin) combined with talk therapy can reduce severe anxiety in people who have been diagnosed with cancer. About 87 adults aged 18 to 80 will receive one of three doses (25 mg, 10 mg, or 1 mg) during an 8-hour therapy session. Th…
Matched conditions: CANCER OF ENDOMETRIUM
Phase: PHASE2 • Sponsor: Psyence Australia Pty Ltd • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC